GREENLAND MINES LTD Partners' Capital Account, Units, Sold in Public Offering
GREENLAND MINES LTD (GRML) reported Partners' Capital Account, Units, Sold in Public Offering of 11.50 million shares for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-23.
Discontinued
us-gaap:PartnersCapitalAccountUnitsSoldInPublicOffering · last filed 2024-05-23
- GREENLAND MINES LTD partners' capital account, units, sold in public offering for the quarter ending 2024-03-31 was 11.50M shares, a 0.00% change year-over-year.
- GREENLAND MINES LTD partners' capital account, units, sold in public offering for the quarter ending 2023-12-31 was 0.00 shares.
- GREENLAND MINES LTD partners' capital account, units, sold in public offering for the quarter ending 2023-09-30 was 0.00 shares.
- GREENLAND MINES LTD partners' capital account, units, sold in public offering for the quarter ending 2023-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- GREENLAND MINES LTD partners' capital account, units, sold in public offering for fiscal 2023 was 11.50M shares, a 0.00% change from fiscal 2022.
- GREENLAND MINES LTD partners' capital account, units, sold in public offering for fiscal 2022 was 11.50M shares.
| Period end | Partners' Capital Account, Units, Sold in Public Offering 3 month | Partners' Capital Account, Units, Sold in Public Offering 6 month | Partners' Capital Account, Units, Sold in Public Offering 9 month | Partners' Capital Account, Units, Sold in Public Offering 12 month |
|---|---|---|---|---|
| 2024-03-31 | 11.50M shares 10-Q · filed 2024-05-23 | 11.50M shares derived: sum of 2 quarters · filed 2024-05-23 | 11.50M shares derived: sum of 3 quarters · filed 2024-05-23 | 11.50M shares derived: sum of 4 quarters · filed 2024-05-23 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-17 | 0.00 shares derived: sum of 2 quarters · filed 2024-04-17 | 0.00 shares derived: sum of 3 quarters · filed 2024-04-17 | 11.50M shares 10-K · filed 2024-04-17 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | 0.00 shares derived: sum of 2 quarters · filed 2023-11-17 | 11.50M shares 10-Q · filed 2023-11-17 | 11.50M shares derived: sum of 4 quarters · filed 2023-11-17 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | 11.50M shares 10-Q · filed 2023-08-21 | 11.50M shares derived: sum of 3 quarters · filed 2023-10-18 | 11.50M shares derived: sum of 4 quarters · filed 2023-10-18 |
| 2023-03-31 | 11.50M shares 10-Q · filed 2023-05-24 | 11.50M shares derived: sum of 2 quarters · filed 2023-10-18 | 11.50M shares derived: sum of 3 quarters · filed 2023-10-18 | 13.00M shares derived: sum of 4 quarters · filed 2023-10-18 |
| 2022-12-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-10-18 | 0.00 shares derived: sum of 2 quarters · filed 2023-10-18 | 1.50M shares derived: sum of 3 quarters · filed 2023-10-18 | 11.50M shares 10-K/A · filed 2023-10-18 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 1.50M shares derived: sum of 2 quarters · filed 2022-11-14 | 11.50M shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 1.50M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 11.50M shares 10-Q · filed 2022-08-15 | ||
| 2022-03-31 | 10.00M shares 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |